MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Teva Pharmaceutical Industries Ltd.

Fechado

SetorSaúde

15.3 0.26

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.07

Máximo

15.34

Indicadores-chave

By Trading Economics

Rendimento

162M

-275M

Vendas

-103M

4.2B

EPS

0.71

Margem de lucro

-6.503

Funcionários

33,892

EBITDA

51M

261M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+56.05% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

18B

Abertura anterior

15.04

Fecho anterior

15.3

Sentimento de Notícias

By Acuity

40%

60%

146 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Teva Pharmaceutical Industries Ltd. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de dez. de 2024, 19:39 UTC

Grandes Movimentos do Mercado

Correction to Teva Articles

17 de dez. de 2024, 16:24 UTC

Grandes Movimentos do Mercado

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

17 de dez. de 2024, 16:14 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Affirm, and More -- Barrons.com

17 de dez. de 2024, 13:51 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More -- Barrons.com

23 de nov. de 2024, 12:00 UTC

Principais Notícias

Emerging-Markets Stocks Have Rarely Been So Hated. It's Time To Buy -- WSJ

22 de ago. de 2024, 05:30 UTC

Principais Notícias

Generic Weight-Loss Drugs Won't Come for Years -- Barrons.com

7 de mai. de 2024, 20:30 UTC

Principais Notícias

Teva Earnings Are Soon. What Could Keep the Stock Gains Going. -- Barrons.com

Comparação entre Pares

Variação de preço

Teva Pharmaceutical Industries Ltd. Previsão

Preço-alvo

By TipRanks

56.05% parte superior

Previsão para 12 meses

Média 23.86 USD  56.05%

Máximo 30 USD

Mínimo 20 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Teva Pharmaceutical Industries Ltd. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

7

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

14.7 / 16.23Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

146 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.